PPBT
Purple BiotechNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$6.31M
P/E Ratio
—
EPS
$-54.00
Beta
-0.70
52W High
$29.40
52W Low
$3.60
50-Day MA
$4.74
200-Day MA
$10.22
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Purple Biotech
Purple Biotech Ltd., a clinical-stage pharmaceutical company, focuses on the development and commercialization of various pharmaceutical drugs in the United States. The company is headquartered in Rehovot, Israel.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | -59,000 |
| EBITDA | $-6.97M |
| Operating Margin | 0.00% |
| Return on Equity | -124.50% |
| Return on Assets | -16.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.01 |
| Price-to-Book | 0.40 |
| Price-to-Sales (TTM) | 58.08 |
| EV/Revenue | 33.07 |
| EV/EBITDA | -0.15 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 929,460 |
| Float | $1.84B |
| % Insiders | 6.51% |
| % Institutions | 11.68% |
Historical Volatility
HV 10-Day
75.65%
HV 20-Day
67.77%
HV 30-Day
77.55%
HV 60-Day
72.36%
HV Rank
—
Volatility is currently contracting
Data last updated: 4/15/2026